Positivt om SLE-behandling

En klinisk studie av ett preparat för att behandla systemisk lupus erythematos, SLE, visade på effekt av behandlingen.

By Totta Kasemo

July 23, 2009 12:00 AM

Glaxosmithkline har i samarbete

med Human Genome Sciences genomfört en fas III-studie av preparatet belimumab. Studien var placebokontrollerad och behandlingen gavs i kombination med standardbehandling.

Studien visar att

den kombinerade behandlingen gav en statistiskt signifikant förbättrad respons hos patienterna. Preparatet tolererades över lag väl.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.